» Articles » PMID: 26352698

Hyaluronidases and Hyaluronan Synthases Expression is Inversely Correlated with Malignancy in Lung/bronchial Pre-neoplastic and Neoplastic Lesions, Affecting Prognosis

Overview
Date 2015 Sep 10
PMID 26352698
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

We collected a series of 136 lung/bronchial and 56 matched lung parenchyma tissue samples from patients who underwent lung/bronchial biopsies and presented invasive carcinoma after lung surgery. The lung/bronchial samples included basal cell hyperplasia, squamous metaplasia, moderate dysplasia, adenomatous hyperplasia, severe dysplasia, squamous cell carcinoma and adenocarcinoma. Matched lung parenchyma tissue samples included 25 squamous cell carcinomas and 31 adenocarcinomas. Immunohistochemistry was performed to analyze for the distribution of hyaluronidase (Hyal)-1 and -3, and hyaluronan synthases (HAS)-1, -2, and -3. Hyal-1 showed significantly higher expression in basal cell hyperplasia than in moderate dysplasia (P=0.01), atypical adenomatous hyperplasia (P=0.0001), or severe dysplasia (P=0.03). Lower expression of Hyal-3 was found in atypical adenomatous hyperplasia than in basal cell hyperplasia (P=0.01) or moderate dysplasia (P=0.02). HAS-2 was significantly higher in severe dysplasia (P=0.002) and in squamous metaplasia (P=0.04) compared with basal cell hyperplasia. HAS-3 was significantly expressed in basal cell hyperplasia compared with atypical adenomatous hyperplasia (P=0.05) and severe dysplasia (P=0.02). Lower expression of HAS-3 was found in severe dysplasia compared with squamous metaplasia (P=0.01) and moderate dysplasia (P=0.01). Epithelial Hyal-1 and -3 and HAS-1, -2, and -3 expressions were significantly higher in pre-neoplastic lesions than in neoplastic lesions. Comparative Cox multivariate analysis controlled by N stage and histologic tumor type showed that patients with high HAS-3 expression in pre-neoplastic cells obtained by lung/bronchial biopsy presented a significantly higher risk of death (HR=1.19; P=0.04). We concluded that localization of Hyal and HAS in lung/bronchial pre-neoplastic and neoplastic lesions was inversely related to malignancy, which implied that visualizing these factors could be a useful diagnostic procedure for suspected lung cancer. Finalizing this conclusion will require a wider study in a randomized and prospective trial.

Citing Articles

Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study.

Gong J, Guan M, Kim H, Moshayedi N, Mehta S, Cook-Wiens G Oncotarget. 2022; 13:1202-1214.

PMID: 36342462 PMC: 9629814. DOI: 10.18632/oncotarget.28304.


Effect of EGCG on bronchial epithelial cell premalignant lesions induced by cigarette smoke and on its CYP1A1 expression.

Gu Q, Chen F, Chen N, Wang J, Li Z, Deng X Int J Mol Med. 2021; 48(6).

PMID: 34676878 PMC: 8559702. DOI: 10.3892/ijmm.2021.5053.


Differential Expression Profiles of Cell-to-Matrix-Related Molecules in Adrenal Cortical Tumors: Diagnostic and Prognostic Implications.

Volante M, Rapa I, Metovic J, Napoli F, Tampieri C, Duregon E J Pers Med. 2021; 11(5).

PMID: 34066306 PMC: 8148197. DOI: 10.3390/jpm11050378.


Hyaluronic Acid: Redefining Its Role.

Abatangelo G, Vindigni V, Avruscio G, Pandis L, Brun P Cells. 2020; 9(7).

PMID: 32708202 PMC: 7409253. DOI: 10.3390/cells9071743.


Prognostic value of immune-related genes in the tumor microenvironment of lung adenocarcinoma and lung squamous cell carcinoma.

Qu Y, Cheng B, Shao N, Jia Y, Song Q, Tan B Aging (Albany NY). 2020; 12(6):4757-4777.

PMID: 32209727 PMC: 7138544. DOI: 10.18632/aging.102871.


References
1.
Nykopp T, Rilla K, Tammi M, Tammi R, Sironen R, Hamalainen K . Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma. BMC Cancer. 2010; 10:512. PMC: 2956733. DOI: 10.1186/1471-2407-10-512. View

2.
Udabage L, Brownlee G, Nilsson S, Brown T . The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer. Exp Cell Res. 2005; 310(1):205-17. DOI: 10.1016/j.yexcr.2005.07.026. View

3.
de Sa V, Olivieri E, Parra E, AbSaber A, Takagaki T, Soares F . Hyaluronidase splice variants are associated with histology and outcome in adenocarcinoma and squamous cell carcinoma of the lung. Hum Pathol. 2011; 43(5):675-83. DOI: 10.1016/j.humpath.2011.06.010. View

4.
de Sa V, Carvalho L, Gomes A, Alarcao A, Silva M, Couceiro P . Role of the extracellular matrix in variations of invasive pathways in lung cancers. Braz J Med Biol Res. 2013; 46(1):21-31. PMC: 3854345. DOI: 10.1590/1414-431x20122263. View

5.
Siiskonen H, Poukka M, Tyynela-Korhonen K, Sironen R, Pasonen-Seppanen S . Inverse expression of hyaluronidase 2 and hyaluronan synthases 1-3 is associated with reduced hyaluronan content in malignant cutaneous melanoma. BMC Cancer. 2013; 13:181. PMC: 3626669. DOI: 10.1186/1471-2407-13-181. View